BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 39 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,174,000 | -15.8% | 60,062 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $3,768,000 | +0.0% | 61,485 | -7.7% | 0.00% | 0.0% |
| Q1 2020 | $3,767,000 | -2.4% | 66,598 | -1.7% | 0.00% | 0.0% |
| Q4 2019 | $3,858,000 | +10.0% | 67,754 | +3.4% | 0.00% | 0.0% |
| Q3 2019 | $3,506,000 | -8.3% | 65,522 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $3,822,000 | +0.6% | 64,006 | +5.0% | 0.00% | 0.0% |
| Q1 2019 | $3,801,000 | -9.6% | 60,978 | -12.1% | 0.00% | 0.0% |
| Q4 2018 | $4,205,000 | +2.3% | 69,376 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $4,109,000 | +30.9% | 70,251 | +0.4% | 0.00% | 0.0% |
| Q2 2018 | $3,140,000 | +0.5% | 69,975 | -0.7% | 0.00% | 0.0% |
| Q1 2018 | $3,124,000 | +4.3% | 70,476 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $2,994,000 | -5.8% | 69,079 | +1.1% | 0.00% | 0.0% |
| Q3 2017 | $3,178,000 | -5.7% | 68,324 | +0.4% | 0.00% | 0.0% |
| Q2 2017 | $3,369,000 | -8.8% | 68,064 | +1.0% | 0.00% | 0.0% |
| Q1 2017 | $3,695,000 | -1.6% | 67,421 | +0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,756,000 | +24.8% | 67,418 | +2.3% | 0.00% | 0.0% |
| Q3 2016 | $3,010,000 | +13.4% | 65,906 | -0.8% | 0.00% | 0.0% |
| Q2 2016 | $2,654,000 | +18.4% | 66,441 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $2,242,000 | -32.8% | 64,378 | -17.0% | 0.00% | 0.0% |
| Q4 2015 | $3,335,000 | +5.4% | 77,598 | +6.8% | 0.00% | 0.0% |
| Q3 2015 | $3,165,000 | -3.0% | 72,682 | +15.0% | 0.00% | 0.0% |
| Q2 2015 | $3,262,000 | +38.8% | 63,226 | +5.4% | 0.00% | 0.0% |
| Q1 2015 | $2,350,000 | +38.8% | 59,996 | +36.9% | 0.00% | – |
| Q4 2014 | $1,693,000 | +9.4% | 43,823 | -0.1% | 0.00% | – |
| Q3 2014 | $1,548,000 | -27.7% | 43,857 | -44.8% | 0.00% | – |
| Q2 2014 | $2,142,000 | +199.2% | 79,486 | +187.7% | 0.00% | – |
| Q1 2014 | $716,000 | +23.9% | 27,626 | +3.6% | 0.00% | – |
| Q4 2013 | $578,000 | +24.6% | 26,661 | +12.0% | 0.00% | – |
| Q3 2013 | $464,000 | – | 23,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
| JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
| NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
| Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
| Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
| Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
| ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
| CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
| ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |